Fully Bayesian imputation model for non-random missing data in qPCR by Sherina, Valeriia et al.
ar
X
iv
:1
91
0.
13
93
6v
1 
 [s
tat
.A
P]
  3
0 O
ct 
20
19
Fully Bayesian
imputation model for
non-random missing
data in qPCR
Journal Title
XX(X):2–13
c©The Author(s) 2016
Reprints and permission:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/ToBeAssigned
www.sagepub.com/
SAGE
Valeriia Sherina1, Matthew N. McCall1,2 and Tanzy M. T. Love1
Abstract
We propose a new statistical approach to obtain differential gene
expression of non-detects in quantitative real-time PCR (qPCR)
experiments through Bayesian hierarchical modeling. We propose to
treat non-detects as non-random missing data, model the missing data
mechanism, and use this model to impute Ct values or obtain direct
estimates of relevant model parameters. A typical laboratory does not
have the resources to perform experiments with a large number of
replicates; therefore, we propose an approach that does not rely on
large sample theory. We aim to demonstrate the possibilities that exist
for analyzing qPCR data in the presence of non-random missingness
through the use of Bayesian estimation. Bayesian analysis typically
allows for smaller data sets to be analyzed without losing power while
retaining precision. The heart of Bayesian estimation is that everything
that is known about a parameter before observing the data (the prior)
is combined with the information from the data itself (the likelihood),
resulting in updated knowledge about the parameter (the posterior). In
this work we introduce and describe our hierarchical model and chosen
prior distributions, assess the model sensitivity to the choice of prior,
perform convergence diagnostics for the Markov Chain Monte Carlo,
and present the results of a real data application.
Keywords
Bayesian model, Missing not at random (MNAR), Quantitative real-time
PCR (qPCR).
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Introduction
There are three missing data mechanisms defined in the statistical
literature: missing completely at random (MCAR), missing at random
(MAR), and missing not at random (MNAR)1,2. Our group previously
showed that the data in qPCR experiments are most likely MNAR3.
Even when the proportion of missing values in a qPCR dataset is not
substantial, it is not appropriate to ignore or remove the genes or samples
with missing values1,2. In both likelihood-based inference and Bayesian,
if the parameters describing the measurement process are functionally
independent of the parameters of the missing data mechanism, the
missingness process is called ignorable, and a non-random process is non-
ignorable4. In MNAR the parameters of the missingness process and the
parameters of the measurement process are not functionally independent,
and hence the process is non-ignorable. This means that in MNAR data we
need to explicitly address the missing data mechanism, because ignoring
it can lead to invalid inference about the model parameters.
To properly characterize the missing data mechanism in qPCR data, we
first need to have a good understanding of the experimental procedures and
the related properties of the measurement instrument. In a typical qPCR
experiment, we start with samples mixed with primers and nucleotides
for the identification and multiplication of the biological material. During
each cycle we expect a doubling of the existing transcript. Due to the
dynamic, real time nature of the qPCR experiment, many factors can
contribute to the presence of missing values in the final qPCR data.
For example, low abundance genes may fail to amplify or the qPCR
instrument may have trouble detecting a weak signal from low-abundance
genes even if amplification occurs. Therefore, the smaller the signal, the
higher the probability of observing a non-detect, a reaction that failed
to be detected by the qPCR technology. Even though these experiments
involve a detection threshold, instead of a censoring model, we utilize a
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probabilistic model proposed by3, and model the missing data process as
a function of the transcript value to be measured.
In this manuscript, we propose a new approach to obtain differential
gene expression for all genes, including non-detects in qPCR experiments
through Bayesian hierarchical modeling. Bayesian analysis does not
assume large samples, as is the case withMaximumLikelihood Estimation
(MLE); typically smaller data sets can be analyzed without losing power
while retaining precision5,6. For more technical details we kindly refer the
reader to7.
The heart of Bayesian estimation is that everything that is known about
a parameter before observing the data (the prior) is combined with the
information from the data itself (the likelihood), resulting in updated
knowledge about the parameter (the posterior). The prior information can
stem from a meta-analysis, previous studies with comparable research
populations, a pilot study, experts, or a range of other sources. If such
knowledge is used we call the prior informative, and if no knowledge
is available (or used) we call the prior uninformative. Estimation of
Bayesian models is frequently done through Markov Chains Monte Carlo
(MCMC). Unlike deterministicMaximum Likelihood algorithms, MCMC
is a stochastic procedure that repeatedly generates random samples that
characterize the posterior distribution of the parameters of interest. This is
distinct from the sampling distribution of estimators which are estimated
by MLE. The process of generating the random samples is the role of the
Markov Chain. The process of generating summary statistics from those
random samples is the role of Monte Carlo integration.
In the study of8, the authors specified an informative prior and
concluded that the more information that is captured by well-specified
priors the smaller the parameter bias. We consider a situation in which, a
priori, there is some information available about the parameters of interest,
so we use uninformative priors, weakly informative priors, or priors
reflecting partial-knowledge of the parameters. In summary, our main
objective is to demonstrate methods to analyze small sample size data
through the use of Bayesian estimation, and to determine the conditions
under which Bayesian inference out performs MLE. This will guide the
analysis of qPCR data in the presence of MNAR data.
We first introduce and describe our hierarchical model and chosen prior
distributions and perform a prior sensitivity analysis. We then present the
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results of a real data application, assess the convergence of the Markov
Chain Monte Carlo, compare parameter estimates with existing methods
described in9, and comment on open problems.
Modeling
Throughout, we analyze the gene expression of I genes. We define a
gene or feature by i. Each gene is measured under different conditions,
perturbations, and in multiple replicates, we will refer to these conditions
and perturbations as k sample-types throughout the paper. J(k) denotes a
partition of the samples into K sets of replicates.
Yij is the observed gene expression of a gene i, sample j in J(k) - a sample
of sample type k ( i = 1, · · · , I; j = 1, · · · , J ; k = 1, · · · , K). For each
Yij there is a Zij such that if Zij = 1, the gene expression is observed, and
if Zij = 0, the value is a non-detect, with
Pr(Zij = 1) =
{
g(Yij) if Yij < 40
0 if otherwise,
(1)
here, g(Yij) is a function that models the dependence between the gene
expression and the probability of the value being observed. The following
logistic regression model is a natural choice of such a relationship:
logit
(
Pr(Zij = 1)
)
= β0 + β1µij, (2)
where β0 and β1 are the logistic regression coefficients, and µij is an
estimate of a gene expression for gene i, sample j that is potentially
unobserved. One of the challenges that arise with the use of µij in
Equation 2 is the presence of non-detects. When we do not have enough
information to generate estimates for the individual µij , a possible solution
is to borrow information across replicates in Jk.
This is the data generating model proposed in3 and described in more
details in9. In this paper, we consider the absolute gene expression, and
model it as follows:
Yij =
{
θikI(j ∈ Jk) + δj + εij if Zij = 1
non-detect if Zij = 0,
(3)
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where Yij is again the observed gene expression or the ∆Ct value from
qPCR experiment, θik is the true gene expression for gene i in the sample-
type Jk, δj represents a global shift in expression across samples, εij
captures the stochastic component of the model.
Bayesian statistics combines the knowledge from the data in the
likelihood with prior information. The prior distribution should reflect
what we know about the parameters in the model. The main parameters
of interest are the average differential gene expression and its variability
(denoted by θ and σ2) together with the missing mechanism parameters,
β0 and β1.
All the parameters in the model need to have a prior distribution.
The specification of the prior distributions consists of three steps.
First, background knowledge is needed as input for the specification.
Such knowledge can stem from a meta-analysis, previous studies with
comparable research populations, a pilot study, experts, or a range of
other sources. In our case, we used existing knowledge of the range
of parameters as inspiration. Second, for all the parameters a type of
distribution has to be specified. We used a Normal distribution, denoted
by N(·, ·), for θ’s; for the standard deviation parameters we specified a
Uniform distribution, denoted by Unif(0, A); and for the probability of
Z = 1we used a Bernoulli distribution, denoted byBern(·). As10 pointed
out, inferences are not sensitive to the choice ofA for at least 3 groups and
sufficiently large finite A.
The third step of the prior specification is to determine the shape of the
prior distribution by means of choosing values of the hyper-parameters.
For the mean parameters θ, the hyper-parameters are the mean and the
standard deviation of the normal distribution, denoted by θ0 and γ. We
fixed the hyper-parameter for the mean of the average gene expression
at θ0 = 60. This constant is larger than the maximum possible observed
∆Ct, so that it pulls all the values of non-detects to be somewhat greater
than the maximum possible observed∆Ct value. However, in the situation
where all the replicates of a sample are non-detects, we really do not have
any information about what the values should have been. Therefore, an
estimate of the∆Ct value being 60 or 80 tells us that there is no confidence
in the presence of gene expression. For the standard deviation parameters
σ, the hyper-parameters are the maximum of the uniform range, this prior
is equivalent to an inverse− χ2 with -1 degrees of freedom, p(σ2) ∝
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σ−1 10. We model β0 and β1 jointly as bivariateGaussian with a zero
mean vector, a variance of 100, and zero correlation. In addition, β1 is
restricted to be positive.
Below is a full specification of our Bayesian Model for the observed
data (Yij, Zij):
Model:
Yij ∼ N(µij , σ
2
i )× I(0,∞), where µij = θik + δj , j ∈ Jk,
Zij ∼ Bern(pij), and logit(pij) = β0 + β1 × µij.
Prior distributions for model parameters:
θik ∼ N(θ0 = 60, γ
2
i ), σi ∼ Unif(0, A), and β ∼ N2(µβ, B)× Iβ1>0,
where A = 10 or 100, µ
β
= (0, 0)′, and B is diag2(100).
Prior for hyper-parameters γi: γi ∼ Unif(0, A).
Posterior distributions
In this section we derived the full conditional distributions of the
parameters of interest and the hyper-parameter γ2. Some of them do not
have a known distributional form. The distribution of the hyper-parameter
γ2, the variance of the mean parameter θ, is:
γ2i |rest ∼ Scaled Inv − χ
2
(
J − 1,
∑
j∈J(k)
(θij − θ0)
2
)
, where θ0 = 60.
p(β|rest) ∝ exp(−
1
2
βB−1β′)× Iβ1>0
×
I∏
i=1
∏
j∈J(k)
(( exp((1, µij)β)
1 + exp((1, µij)β)
)Zij
×
( 1
1 + exp((1, µij)β)
)1−Zij)
(4)
σ2i |rest ∼ Scaled Inv − χ
2
(
J − 1,
∑
j∈J(k)
(Yij − θij − δj)
2
)
(5)
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p(θij |rest) ∝
I∏
i=1
N
(
µθ,Σθ
)
×
∏
j∈J(k)
(( exp((1, µij)β)
1 + exp((1, µij)β)
)Zij
×
( 1
1 + exp((1, µij)β)
)1−Zij)
(6)
where
µθ = ((σ
2
i )
−1 + (γ2i )
−1)−1 × ((σ2i )
−1 1
J(k)
∑
j∈J(k)
(Yij − δj) + (γ
2
i )
−1 × θ0),
and
Σθ = ((σ
2
i )
−1 + (γ2i )
−1)−1.
Parameter estimation
We consider two ways of summarizing the output from the MCMC:
1. Fully Bayesian Imputation (FBI). By taking a median of all draws for
the parameters of interest, θs and σ2s, we acquire direct parameter
estimates of the mean and the variance of gene expression.
2. Single Imputation Bayesian (SI Bayes). By taking the median of
draws of missing y, we obtain single imputation for individual
missing data points. We further calculate means and the variances
of gene expressions to get the values of parameters for this method.
Note that we expect the variance to be under-estimated here because
we are ignoring the fact that some y are missing and treating
estimates of y as data.
Simulation study
Based on the design and the parameters of the experimental data from11
we selected the true values of the model parameters to be used in our
simulation study. We set β0 = −35.7 and β1 = 1, the number of genes to
16, the number of replicates, the length of J(k), within each sample type
to 6, and the number of sample types K, we also set to 6. We assume the
missing mechanism is common across all genes.
Prepared using sagej.cls
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To generate synthetic data, we first simulate complete data, then remove
part of the data by constructing a MNAR data mechanism. In the first
step, we generate three components: true θik, δj , and εij . We generate θik
from N(µθ, σ
2
θI), we set σ
2
θ = 3 and µθ we generate from a N(31, 3.5
1/2)
truncated from 20 to 40.5. δj we set to 0, and simulate εij fromN(0, σ
2
i I),
where true σ2i are coming from Unif(0.06, 1.3). In the second step we
generate the missing data indicators from Binom(pij), where pij is the
probability of a point being missing according to the logit model proposed
in the Equation 2 calculated for each data point. All the individual Ct
values ≥ 40 and values with missing indicators are replaced with a value
of 40, indicating a non-detect.
We compared performance under several prior distributions and
assessed sensitivity to the choice of prior. For every scenario we ran 100
simulations.We summarize the results as the 25th, 50th, and 75th quantiles
of bias and MSE for all genes and samples. We have 16 genes and 6
sample-types, so for each synthetic data set there are 16 distinct values
of σ2i and 16×6=96 different θik. We show results for FBI because they
are better, results for SI Bayes are shown in the application.
Prior sensitivity analysis
The importance of prior sensitivity analysis is hard to overestimate; the
choice of prior distributions is influential on the estimation results. The
more information that is captured by well-specified priors the smaller
resulting parameter bias. We looked at several choices of prior distribution
for variability components of the model. We specified priors for σ and
γ, or σ2 and γ2. We compared the conjugate inverse gamma priors
with varying parameters and weakly informative uniform priors with two
different boundaries: (0, 10) and (0, 100). The summary of Bias and MSE
for the mean (θ) and the variance components (σ2) are given in Table 1.
The θ estimates are unbiased, while σ2 is slightly overestimated,
meaning that this fully Bayesian model incorporates additional
uncertainty into the estimation of the variance. MSE’s are higher for θ
and lower for σ2 due to the bias variance trade off. The estimation results
vary for IG(w1, w2) priors, in contrast, the results for Unif(0, A) priors
are consistent and almost identical across different ranges. Therefore,
in the real data application, we decided to use the uniform distribution.
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Bias MSE
σ2 ∼ Unif(0, 100), γ2 ∼ Unif(0, 100)
θ −0.032 -0.011 0.012 0.100 0.122 0.137
σ2 0.025 0.033 0.040 0.033 0.048 0.062
σ2 ∼ Unif(0, 10), γ2 ∼ Unif(0, 10)
θ −0.003 0.016 0.047 0.099 0.120 0.138
σ2 0.026 0.036 0.044 0.034 0.049 0.064
σ2 ∼ IG(0.001, 0.5), γ2 ∼ IG(0.1, 0.1)
θ −0.031 -0.010 0.013 0.102 0.124 0.139
σ2 0.042 0.047 0.049 0.034 0.048 0.061
σ2 ∼ IG(0.001, 0.5), γ2 ∼ IG(0.001, 0.5)
θ −0.031 -0.010 0.013 0.102 0.124 0.139
σ2 0.042 0.047 0.049 0.034 0.048 0.061
σ2 ∼ IG(0.001, 0.5), γ2 ∼ IG(1, 10)
θ −0.030 -0.008 0.014 0.103 0.124 0.139
σ2 0.042 0.046 0.049 0.034 0.048 0.061
σ2 ∼ IG(0.001, 0.5), γ2 ∼ IG(0.001, 0.001)
θ −0.031 -0.010 0.013 0.102 0.124 0.139
σ2 0.042 0.047 0.049 0.034 0.048 0.061
σ2 ∼ IG(1, 10), γ2 ∼ IG(0.001, 0.001)
θ −0.025 -0.004 0.016 0.208 0.232 0.247
σ2 0.646 0.670 0.701 0.577 0.587 0.621
σ2 ∼ IG(0.001, 0.001), γ2 ∼ IG(0.001, 0.001)
θ −0.032 -0.011 0.012 0.096 0.118 0.132
σ2 0.003 0.008 0.011 0.029 0.041 0.054
Table 1. Varying prior distributions for γ2 and σ2.
If a researcher knows more information about the distribution of the
parameters, they have the ability to specify the prior in our model.
Experimental data application
To study the performance of the proposed methods and compare them to
existing methods of imputing MNAR data, we used an experimental study
of the effect of p53 and/or Ras mutations on gene expression with 3 or 4
replicates per sample-type12. Real data applicability is an essential part of
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testing new methods, and when testing new methods for missing data, it is
important to know the true values.
The data set has a small amount of missing values, about 3%. To have a
complete data set, we started with removing all the genes with missing
values. We call this data set complete. Thereafter, we replaced all the
∆Ct values greater or equal to 30 with 30, this resulted in a truncated
data set with 2% of missing values found in 12% of unique genes. We
use this dataset in testing FBI and SI Bayes. We initiated MCMC and
obtained 10000 draws from posterior distributions of the parameters β,
θ, σ2, and y. The average effective sample size of the parameters is 4872.
We calculated estimates using FBI and SI Bayes methods. Thereafter, we
calculate the difference between parameter estimates from experimental
data and from several existing methods, such as a Penalized EM algorithm
incorporating missing-data mechanism (PEMM), a Direct Estimation
(DirEst), a Multiple Imputation (MI), and present the results in Figure ??.
We compared the proposed FBI and SI Bayes methods to estimates
simply using the truncated data (Trunc), a penalized EM algorithm
incorporating non-randommissingness (PEMM) proposed by13, and MLE
based methods: DirEst andMI, proposed by our group9. PEMM calculates
Pr(Y |Z = 1) = constant× exp(−φ×Y ) for positive Y , where φ is the
parameter in the missing-data mechanism; we set φ = 1. We calculated
θˆ and σˆ2 for PEMM, DirEst, MI, SI Bayes, and FBI, and compared them
to the estimates from the complete data.
We then repeated the same process with truncating ∆Ct values at 33.
This time the resulting data has overall 1% of missing values that occur
in 7% of unique genes. The average effective sample size in the MCMC
draws for the parameters is 4980. The results of this study are presented
in Figure ??.
FBI outperforms MLE based methods
When there is a small % of missing data, there is very little information
about the missing data mechanism, common across all the genes. Our
Bayesian modeling framework allows for better estimation of the missing
mechanism in the presence of a small amount of non-detects. There has
been a lot of attention drawn to methods that can accommodate large
proportions of missing data, some methods have shown to be successful,
for example 13. In a laboratory setting with limited resources, researchers
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work with only a few replicates per condition, and missing data is rather
unusual. When the missing data mechanism is non-ignorable, researchers
are more likely to utilize and rely on methods that are tailored to estimate
the missing data mechanism better with less available information about
it.
We see that for the data truncated at 30, DirEst and MI slightly
outperform fully Bayesian imputation in estimating the average gene
expression, while SI Bayes substantially underestimates gene expression
in comparison to PEMM and even truncated data mean estimates. The
FBI shows very similar performance to DirEst and MI in terms of bias for
σ2, while SI Bayes has higher bias, which shows that single imputation
procedures are generally sub-optimal when dealing with non-random
missing data.
When there is not a lot of information about the missing data
mechanism, we see the advantage of using FBI over likelihood based
approaches (Figure ??). The bias and MSE (not shown) for the mean
and the variance are smallest for FBI, compared to all other approaches.
Recall that in this example, the missing data is only 1% of the total data.
This demonstrates that FBI can better estimate the gene expression and
variability needed to identify deferentially expressed genes.
Discussion
In genomic studies researchers usually have a limited number of samples.
They can not sacrifice the information from the data with small number
of samples by simply ignoring the observations with missing values,
especially when the data is missing not at random. We proposed a fully
Bayesian imputation method that works well for small samples sizes. For
the purpose of this work, we assume there is one common missing data
mechanism for the entire experiment.
In the simulation study we assessed the bias and MSE of the
model parameters, performed a sensitivity analysis, and showed that our
method is not sensitive to the choice of prior. We recommend using
a non-informative uniform prior, but our method can be customized if
information about the priors are available.
We compared this new approach with other existingmethods for missing
data imputation on an experimental dataset. The real data application
revealed that fully Bayesian imputation is better than other methods
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when there is not a lot of information about the missing data mechanism
available. Moreover, it performs similarly to MLE based approaches
when the proportion of missing data increases, and hence information
about the missing data mechanism increases. In experimental situations,
investigators try to limit missing data and often do not have more than 3-4
replicates per condition. Therefore, it is useful to show that this method
can work well when there is moderate missingness and is better than other
proposed methods when the missingness is limited.
In this work, we assume that each gene has common variance across
sample types and gene expressions are normally distributed. It is possible
to build a model with a genes by sample types covariance matrix, but this
is beyond the scope of this work. The framework of FBI can be extended
to non-Normal distributions and also other missing data mechanisms;
however, this may require modifications to the model.
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